Xiongwei Zhu, PhD
Professor of Pathology and Neurology, School of Medicine, Case Western Reserve University
Director, Graduate Program, Department of Pathology, School of Medicine, Case Western Reserve University
Director, NIH-Sponsored Neurodegenerative Disease T32 Training Grant
Research Education Component Leader
Dr. Zhu is Professor of Pathology and of Neurology at Case Western Reserve University School of Medicine (CWRU) in Cleveland, Ohio. He is a researcher, and educator who has devoted himself to the study of pathogenic mechanism underlying Alzheimer’s disease and related neurodegenerative diseases. He is the Director of Pathology Graduate Program at Department of Pathology, School of Medicine, CWRU and Director of NIH-sponsored Neurodegenerative Disease T32 Training Grant.
Dr. Zhu’s research interests have focused on oxidative stress signaling and mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease and related disorders (ADRD). During the last two decades, he maintains a competitive research program that has been continuously funded by National Institute on Aging (NIA) and National Institute of Neurological Disorders and Stroke (NINDS). He has also been the recipient of multiple research grants including support from National Aeronautics and Space Administration (NASA), Alzheimer’s Association, as well as a variety of private foundations, and industry-sponsored grants.
Dr. Zhu has devoted large efforts in research education and has mentored numerous trainees at different levels from undergraduate students, graduate students, medical students to postdoctoral and junior faculty. He has published extensively with his trainees. He has authored or co-authored over 280 peer-reviewed publications on ADRD related topics.
Dr. Zhu has been a guest lecturer at numerous academic and community settings, both on a national and international level. He is an active editorial member for more than ten reputable international journals in the field of neuroscience and neurodegeneration and is currently Deputy Chief Editor for Journal of Alzheimer’s Disease and Journal of Neurochemistry. He routinely reviews grant applications for National Institute of Health (NIH), NASA, Veteran Health Administration (VA), Department of Defense (DOD) and other national and international funding organizations.